
Diabetes
A short sentence to introduce what to expect in the about condition
section
Learn moreThis is an intervention, phase IV, single-arm study to assess the safety and efficacy of iGlarLixi in adult patients with Type 2 diabetes.
The prescreener preview is complete. You may now close the preview.